These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37482714)

  • 1. [Association between metabolism-related chronic disease combination and prevalence of non-alcoholic fatty liver disease in community residents in Shanghai].
    Wang YY; Zhao Q; Chen B; Wang N; Zhang TJ; Jiang YG; Wu YL; He N; Zhao GM; Liu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Jul; 44(7):1106-1113. PubMed ID: 37482714
    [No Abstract]   [Full Text] [Related]  

  • 2. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
    Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
    Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
    Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and factors of nonalcoholic fatty liver disease among elderly in Shenzhen City in 2018].
    Yuan X; Ni W; Li P; Zhang H; Zhang Y; Xu J
    Wei Sheng Yan Jiu; 2022 Jul; 51(4):585-590. PubMed ID: 36047263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China.
    Kong L; Yang Y; Li H; Shan Y; Wang X; Shan X
    Front Public Health; 2023; 11():1127489. PubMed ID: 37077190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort.
    Zhou X; Li Y; Zhang X; Guan YY; Puentes Y; Zhang F; Speliotes EK; Ji L
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3156. PubMed ID: 30892820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey.
    Hu XY; Li Y; Li LQ; Zheng Y; Lv JH; Huang SC; Zhang W; Liu L; Zhao L; Liu Z; Zhao XJ
    BMJ Open; 2018 Apr; 8(4):e019974. PubMed ID: 29626047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
    Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
    Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.
    Zhou Z; Song K; Qiu J; Wang Y; Liu C; Zhou H; Xu Y; Guo Z; Zhang B; Dong C
    PLoS One; 2016; 11(11):e0166072. PubMed ID: 27835657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units.
    Hu X; Huang Y; Bao Z; Wang Y; Shi D; Liu F; Gao Z; Yu X
    BMC Gastroenterol; 2012 Sep; 12():123. PubMed ID: 22978800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.